Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent Developments in Coated Stents.

Sjoerd H. Hofma1, Heleen M.M. van Beusekom, Patrick W. Serruys

  • 1Thoraxcenter, Erasmus Medical Center Rotterdam, Dr. Molewaterplein 40, Room Bd 412, Rotterdam 3015 GD, The Netherlands. vandergiessen@card.azr.nl

Current Interventional Cardiology Reports
|February 15, 2001
PubMed
Summary

Optimizing stent coatings improves hemocompatibility and tissue integration, crucial for preventing restenosis, especially in complex cases. New drug-eluting stents show promise for better treatment outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sirolimus-coated Stent Prevents Neointimal Proliferation.

Current interventional cardiology reports·2001
Same author

Three-Dimensional Myocardial Perfusion Maps by Contrast Echocardiography.

Echocardiography (Mount Kisco, N.Y.)·1997
See all related articles

Area of Science:

  • Biomaterials Science
  • Cardiovascular Medicine
  • Medical Device Engineering

Background:

  • Stent coatings are critical for improving hemocompatibility and tissue integration.
  • Optimizing stent design and coatings is essential for treating various lesion types, including complex ones.
  • Current treatments for restenosis and in-stent restenosis yield suboptimal results, highlighting the need for preventative strategies.

Purpose of the Study:

  • To review the advancements in stent coating technology for enhanced hemocompatibility and tissue compatibility.
  • To emphasize the importance of preventing restenosis, particularly in-stent restenosis.
  • To discuss the potential impact of new drug-eluting stents on improving treatment outcomes.

Main Methods:

  • Literature review of studies on stent coatings, hemocompatibility, tissue compatibility, and restenosis.

Related Experiment Videos

  • Analysis of current treatment outcomes for restenosis and in-stent restenosis.
  • Exploration of ongoing clinical trials involving novel drug-eluting stents.

    • Main Results:

    • Stent coating optimization significantly enhances hemocompatibility and tissue integration.
    • Prevention is key to managing refractory restenotic lesions, where treatment outcomes are poor.
    • New drug-eluting stents, including those with rapamycin, are emerging as a promising advancement.

    Conclusions:

    • Continued research into stent coatings is vital for improving cardiovascular device performance.
    • Preventative measures and advanced stent technologies are crucial for addressing the challenges of restenosis.
    • Drug-eluting stents represent a significant step forward in managing complex coronary artery lesions and improving patient outcomes.